Some popular versions of uninformed consent

Health Care Analysis

Volumn 8, Issue 1, 2000, Pages 41-53

  Hutton, Jane L ^a   Ashcroft, Richard E ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Autonomy; Distress; Double standards; Experimental treatment; Informed consent; Justice; Randomised controlled trials; Refusal

Indexed keywords

DOCTOR PATIENT RELATION; EXPERIMENTATION; HUMAN; INFORMED CONSENT; PATIENT INFORMATION; PATIENT RIGHT; REVIEW;

EID: 0034037439     PISSN: 10653058     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009421824028     Document Type: Review

References (33)

1. Ashcroft, J.J., Leinster, S.J. and Slade, P.D. (1985) Breast Cancer - Patient Choice of Treatment: Preliminary Communication. Journal of the Royal Society of Medicine 78, 43-46.
2. Ashcroft, R.E., Chadwick, D.W., Clark, S.R.L., Edwards, R.H.T., Frith, L. and Hutton, J.L. (1997) Implication of socio-cultural contexts for the ethics of clinical trials. Health Technology Assessment 1(9), iv + 65.
3. Baum, M. (1986) Do We Need Informed Consent? The Lancet, 911-912.
4. Baum, M. (1993) New Approach for Recruitment into Randomised Controlled Trials. The Lancet 341 812-813.
5. Berry, D.A. (1993) The Case for Bayesianism in Clinical Trials. In D. Ashby (Ed.), Papers from the Conference on Methodological and Ethical Issues in Clinical Trials, 27-28 June 1991, Vol. 12, Statistics in Medicine, Wiley, pp. 1377-1393.
6. Brazier, M. (1992) Medicine, Patients and the Law (2 edn.). Harmondsworth: Penguin.
7. Bursztajn, H.J., Feinbloom, R.I., Hamm, R.M. and Brodsky, A. (1990) Medical Choices, Medical Chances (2 edn.). New York and London: Routledge.
8. Caplan, A. (1988) Is There an Obligation to Participate in Biomedical Research? In S.F. Spicker et al. (Eds.), The Use of Human Beings in Research, with Special Reference to Clinical Trials. Dordrecht: Kluwer.
9. Chalmers, I. (1983) Scientific Inquiry and Authoritarianism in Perinatal Care and Education. Birth 10, 151-164.
10. Chalmers, I. and Silverman, W. (1987) Professional and Public Double Standards on Clinical Experimentation. Controlled Clinical Trials 8, 388-391.
11. Council of the International Organisation of Medical Sciences (1993) International Guidelines for Biomedical Research Involving Human Subjects, esp. Guidelines 1-3.
12. Edwards, S.J.L., Lilford, R.J., Braunholtz, D.A., Jackson, J., Hewison, J. and Thornton, J. (1998) Ethical Issues in the Design and Conduct of Randomised Controlled Trials. Health Technology Assessment 2(15), vi + 128.
13. Hanauske-Abel, H.M. (1996) Not a Slippery Slope or Sudden Subversion: German Medicine and National Socialism in 1993. British Medical Journal 313, 1453-1463.
14. Harrison, J. (1996) Patients Should not be Discouraged from Entering Trials. British Medical Journal 313, 1488.
15. Hilden, J. and Habbema, J.D.F. (1987) Prognosis in Medicine: An Analysis of Its Meaning and Roles. Theoretical Medicine 8, 349-365.
16. Hilden, J. and Habbema, J.D.F. (1990) The Marriage of Clinical Trials and Clinical Decision Science. Statistics in Medicine 9, 1243-1257.
17. Hill, A.B. (1992) Statistical Methods in Clinical and Preventive Medicine. Edinburgh and London: E & S Livingstone.
18. Beecher, H.K. (1970) Research and the Individual. London: J&A Churchill.
19. Hutton, J.L. (1995) Statistics is Essential for Professional Ethics. Journal of Applied Philosophy 12, 253-261.
20. Hutton, J.L. (1996) The Ethics of Randomised Controlled Trials: A Matter of Statistical Belief. Health Care Analysis 4, 95-102.
21. Hutton, J.L. (1998) Medical Ethics and Statistics. In D.G. Altman et al. (Eds.), Encyclopedia of Biostatistics. London: John Wiley and sons, pp. 2540-2546.
22. Koehn, D. (1994) The Ground of Professional Ethics. London: Routledge.
23. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1978) The Belmont Report: Ethical Guidelines and Principles for the Protection of Human Subjects of Research. Washington, DC: US government printing office. BHEW publication (OS)78-0012.
24. Nuremberg Code (1947); see (1996) British Medical Journal 313, 1449.
25. Pocock, S.J. (1992) When to Stop a Clinical Trial. British Medical Journal 305, 235-240.
26. Prescott, R., Gillespie, W., Counsell, C., Grant, A.M., Ross, S., Russell, I. and Kiauka, S. (1998) Factors that Limit the Number, Quality and Progress of Randomised Trials. In N. Black et al. (Eds.), Health Services Research Methods. London: BMJ Books, pp. 86-97.
27. Taylor, K.M., Margolese, R.G. and Soskolne, C.L. (1984) Physicians' Reasons for not Entering Eligible Patients in a Randomized Clinical Trial of Surgery for Breast Cancer. New England Journal of Medicine 310, 1363-1367.
28. Thornton, H. (1992) Breast Cancer Trials: A Patient's Viewpoint. The Lancet 339, 44-45.
29. Thornton, H. (1994) Clinical Trials - a Brave New Partnership. Journal of Medical Ethics 20, 19-22.
30. Toynbee, P. (1996) No One Really Wins in This Life-and-death Lottery. The Independent May 25, 15 (cols 1-7).
31. Vollmann, J. and Winau, R. (1996) Informed Consent in Human Experimentation before the Nuremberg Code. British Medical Journal 313, 1445-1450.
32. World Medical Association (1996) Declaration of Helsinki (1964, 1975, 1983, 1989, 1996, currently under review), see (1996). British Medical Journal 313, 1449-1450.
33. Zelen, M. (1979) A New Design for Randomized Clinical Trials. New England Journal of Medicine 300, 1242-11245.